SGM-101 in Locally Advanced and Recurrent Rectal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rectal Cancer
- Recurrent Rectal Cancer
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Prospectively inclusion treatment arm. Compared to historical cohort.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04642924
- Collaborators
- Erasmus Medical Center
- VU University Medical Center
- Catharina Ziekenhuis Eindhoven
- Medical Center Haaglanden
- Surgimab
- Quest Medical Imaging
- Centre for Human Drug Research, Netherlands
- Investigators
- Not Provided
Get Well Soon